BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 18834079)

  • 1. RACI rescinded.
    Conde C
    Tex Med; 2008 Sep; 104(9):18-25. PubMed ID: 18834079
    [No Abstract]   [Full Text] [Related]  

  • 2. Fee frenzy.
    Ortolon K
    Tex Med; 2006 Apr; 102(4):22-6. PubMed ID: 17128754
    [No Abstract]   [Full Text] [Related]  

  • 3. Cheap or good.
    Borges W
    Tex Med; 2004 Aug; 100(8):24-9. PubMed ID: 15386975
    [No Abstract]   [Full Text] [Related]  

  • 4. Blue Cross Blue Shield plans launch incentives despite physicians' concerns.
    Fine A
    Manag Care Q; 2006; 14(1):26. PubMed ID: 17590976
    [No Abstract]   [Full Text] [Related]  

  • 5. Mo' better blues.
    Borges W
    Tex Med; 2003 Apr; 99(4):33-5. PubMed ID: 12723419
    [No Abstract]   [Full Text] [Related]  

  • 6. Blue Cross blues.
    Borges W
    Tex Med; 2001 Mar; 97(3):30-6. PubMed ID: 11320961
    [No Abstract]   [Full Text] [Related]  

  • 7. CA Blue Cross using quality to reward physician performance.
    Data Strateg Benchmarks; 2002 Nov; 6(11):161-7. PubMed ID: 12528483
    [No Abstract]   [Full Text] [Related]  

  • 8. Health plans & technology. Processing for profitability.
    Health Manag Technol; 2005 Feb; 26(2):38, 40. PubMed ID: 15756993
    [No Abstract]   [Full Text] [Related]  

  • 9. What the Blues have in store for you.
    Gerber PC
    Physicians Manage; 1986 Jan; 26(1):67-72. PubMed ID: 10275704
    [No Abstract]   [Full Text] [Related]  

  • 10. Why provider-sponsored plans' admin cost are lower than commercial, Blue Cross plans.
    Capitation Manag Rep; 2004 Feb; 11(2):21-3, 13. PubMed ID: 15085776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCBS & CPOE. BCBSMA is sweetening the CPOE deal by providing greater financial incentives for adoption.
    Lawrence D
    Healthc Inform; 2008 May; 25(5):20, 22-4, 26. PubMed ID: 18524180
    [No Abstract]   [Full Text] [Related]  

  • 12. IBC fee schedule revisions prompt rebuttal.
    Pa Med; 1998 Sep; 101(9):1. PubMed ID: 9782701
    [No Abstract]   [Full Text] [Related]  

  • 13. California plan hikes premiums, reduces payments to providers.
    de Lafuente D
    Mod Healthc; 1993 Jun; 23(23):11. PubMed ID: 10126287
    [No Abstract]   [Full Text] [Related]  

  • 14. Worse than the BCS.
    Conde C
    Tex Med; 2008 Jan; 104(1):21-7. PubMed ID: 18396769
    [No Abstract]   [Full Text] [Related]  

  • 15. Blue Cross rate renewal numbers looking good.
    Stafford E
    J Mich Dent Assoc; 2005 Nov; 87(11):24. PubMed ID: 16372543
    [No Abstract]   [Full Text] [Related]  

  • 16. Blue Cross president sees joint ventures as objective delivery/financing linkage.
    Tresnowski BR
    Rev Fed Am Hosp; 1986; 19(1):39-40. PubMed ID: 10275826
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug trend data provide benchmarks for Blue Cross Blue Shield Plans.
    Capitation Rates Data; 2005 Jul; 10(7):82-4. PubMed ID: 16170955
    [No Abstract]   [Full Text] [Related]  

  • 18. Discounted Medicare? It's already here.
    Terry K
    Med Econ; 2000 May; 77(10):53-6, 63-4, 67. PubMed ID: 11010250
    [No Abstract]   [Full Text] [Related]  

  • 19. Promises, promises.
    Conde C
    Tex Med; 2008 Apr; 104(4):18-24. PubMed ID: 18610863
    [No Abstract]   [Full Text] [Related]  

  • 20. Legal structure of and issues presented by the proposed reorganization of Empire Blue Cross and Blue Shield.
    Mancino DM
    Bull N Y Acad Med; 1997; 74(2):206-12. PubMed ID: 9439858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.